Table of Contents
Lecture
| Current status and advances in lung cancer vaccine | |
| Qinghua ZHOU, Jianjun QIN, Wen ZHU | 241-244 |
Basic Research
| Study on the effects of p53 deletion and mutation on malignant phenotype of human lung cancer cell line | |
| Hui WANG, Baitang LAI, Jinzhao LI, Xuehui YANG, Chunyan ZHANG, Wentao YUE, Hongtao ZHANG, Xi LI, Xiuping ZHAN, Yue WANG | 245-249 |
| Detection of methylation and deletion of p16 gene in non-small cell lung cancer | |
| Mengqing PENG, Xu WANG, Delin LIU, Tao LUO, Jie CHEN, Xingzhi HAO | 250-253 |
| Cisplatin-induced apoptosis in human lung adenocarcinoma cell line A549 | |
| Wenzhe LIU, Jinhan LI, Yide HU, Guisheng QIAN | 254-256 |
| Apoptosis-inducing effect of Tanshinone and its molecular mechanism on human lung cancer cells | |
| Jintao HE, Qinghua ZHOU, Shulan YUAN, Yanping WANG, Xiaohe CHEN, Jianjun QIN | 257-259 |
| Expression of E-cadherin in non-small cell lung cancer: correlation with lymphatic metastasis and prognosis | |
| Xiaofeng CHEN, Jiaan DING, Wen GAO, Xianghua YI, Haifeng WANG, Hua LI | 260-262 |
| A study on the relationship between E-cadherin, β-catenin expression and metastasis and prognosis in non-small cell lung cancer | |
| Xiaojun TANG, Qinghua ZHOU, Shangfu ZHANG, Lunxu LIU, Niang CHENG | 263-267 |
Clinical Research
| Decline of dendritic cells in the peripheral blood of patients with non-small cell lung cancer and its relation to vascular endothelial growth factor | |
| Xiaohong FAN, Qianggang DONG, Guoliang BAO, Baohui HAN, Meilin LIAO, Chengxin GAO | 268-271 |
| The primary applications of 153 Sm-EDTMP plus chemotherapy in the treatment of bone metastasis of lung cancer | |
| Houfu DENG, Qinghua ZHOU, Tianzhi TAN, Shunzhong LUO, Xiying ZHANG, Anren KUANG, Zhenglu LIANG, Lin LI, Yunchun LI, Li CHAI, Xiaochuan YANG, Quanlin WANG, Tingshu MO, Mingzhi PAN, Shu HU, Yong LEI, Lili MA | 272-274 |
| The clinical significance of detection of telomerase in bronchoalveolar lavage liquid in patients with lung cancer | |
| Xianfa JIAO, Guobin WANG, Jianling QIN, Feng WANG, Ning WANG | 275-277 |
| Expression and clinical significance of nm23-H1 and CD44v6 in non-small cell lung cancer | |
| Zitong WANG, Haiqing ZHANG, Shiye LI | 278-281 |
| Surgical treatment of lung cancer via intrapericardial vascular management: A report of 56 cases | |
| Renye KOU, Guiwu SUN, Zhiqiang ZOU, Lei YUAN, Shining XU, Bin MA | 282-283 |
| The role of transbronchial needle aspiration in the staging of bronchogenic carcinoma | |
| Rui WANG, Jianjing HAN, Jifang YAO, Zenglin WANG | 284-286 |
| Surgical treatment of primary pulmonary low-grade malignant carcinoma | |
| Ming HAN, Junzhong RUAN, Xiuyi ZHI | 287-289 |
| The efficacy and toxicity of the FUDR-based regimen in the treatment of advanced non-small cell lung cancer | |
| Shuqin WANG, Wei LIU, Yuhua WANG, Baoe ZHAI | 290-292 |
| Clinical combination therapy for adrenal metastasis from lung cancer | |
| Hongying LI, Yunhua BAO | 293-294 |
Clinical Experience
| 肺癌侵及上腔静脉的外科治疗 | |
| 陈 静瑜, 郑 明峰, 朱 大伟, 何 毅军, 朱 乾坤, 陈 若 | 295-297 |
| 肺大泡合并肺癌32例外科疗效 | |
| 谢 博雄, 丁 嘉安, 唐 明娟, 吴 琨 | 298-299 |
| 61例肺大细胞癌临床特点分析 | |
| 于 大平, 白 连启, 闫 东杰, 杨 声, 李 世业 | 300-301 |
| 70岁以上肺癌患者围手术期治疗 | |
| 李 东文, 田 大力, 胡 永校, 赵 惠儒, 殷 洪年, 李 厚文 | 302-303 |
| 血清TSGF与CEA联合检测在肺癌诊断中的价值 | |
| 曹 轶林, 蒋 莉, 杨 建彬 | 304-305 |
| NP和IEP方案治疗晚期NSCLC的对比观察 | |
| 张 丽杰, 孙 文洲, 郭 子姮 | 306-307 |
| 紫杉醇联合化疗治疗非小细胞肺癌临床疗效观察 | |
| 廖 国清, 王 红梅, 刘 鹏辉, 曲 怡梅, 戴 海峰, 解 国清 | 308-309 |
Minireview
| 表皮生长因子受体酪氨酸激酶抑制剂抗肿瘤治疗的临床进展 | |
| 张 晓彤, 李 龙芸 | 310-312 |
| 肺癌耐药机制的研究进展 | |
| 刘 凌志, 黄 桂君, 钱 桂生 | 313-315 |
| 上皮细胞钙粘素及相关蛋白与肺癌关系的研究进展 | |
| 陈 清勇, 周 建英, 王 彦刈, 郑 筱祥 | 316-318 |
| 吉西他滨放射增敏作用的研究进展 | |
| 李 昌林, 侯 梅 | 319-320 |
Short Communications
| CT引导下经皮肺穿刺活检技术的临床应用 | |
| 柳 江, 陈 锐 | 256 |
| 外科治疗侵及左心房ⅢB期肺癌七例报告 | |
| 林 江泉, 林 链凤, 邱 明义, 吴 健, 高 翔, 胡 树桥 | 259 |
| HP方案治疗广泛期小细胞肺癌近期疗效观察 | |
| 宫 海涛, 陈 学明 | 292 |
| 血清CA125测定对肺癌诊断和预后价值的初探 | |
| 林 红, 吴 薇, 罗 辉, 杜 力群 | 297 |
Case Reports
| 双侧中心型多原发肺癌一例 | |
| 王 瑞娟, 贾 晓君, 赵 尔增 | 286 |
